15 min listen
Hepatitis C: must address drivers of the disease, not just treatment
FromCMAJ Podcasts
ratings:
Length:
12 minutes
Released:
Aug 4, 2015
Format:
Podcast episode
Description
Interview with Dr. Mark Tyndall, infection disease specialist, Professor of Population and Public Health at the University of British Columbia, and Executive Director of the BC CDC. In a commentary published in CMAJ, Dr. Tyndall draws attention to the fact that although new treatments for hepatitis C virus are much more effective, we must not forget to address the social drivers of the disease, especially amongst people who inject drugs. IV drug users, both current and past, make up the majority in the second wave of HCV infection. Full article: https://www.cmaj.ca/lookup/doi/10.1503/cmaj.150612To request a transcript of this podcast, contact cmajgroup@cmaj.ca
Released:
Aug 4, 2015
Format:
Podcast episode
Titles in the series (100)
Mediterranean diet, taxing unhealthy food, non-cow's milks & vit D, physician-assisted dying & more by CMAJ Podcasts